Nurami Medical Revenue and Competitors

Haifa, IL

Location

$10M

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Nurami Medical's estimated annual revenue is currently $7.9M per year.(i)
  • Nurami Medical's estimated revenue per employee is $305,231
  • Nurami Medical's total funding is $10M.

Employee Data

  • Nurami Medical has 26 Employees.(i)
  • Nurami Medical grew their employee count by 8% last year.

Nurami Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Inventor, Co-founder, BOD and CTOReveal Email/Phone
3
COO & Clinical Director, co-FounderReveal Email/Phone
4
VP CommercializationReveal Email/Phone
5
Clinical Trials ManagerReveal Email/Phone
6
Research And Development EngineerReveal Email/Phone
7
Process EngineerReveal Email/Phone
8
Senior R&D and Product EngineerReveal Email/Phone
9
Research And Development EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.9M1330%N/AN/A
#2
$1.1M6200%N/AN/A
#3
$9.2M303%N/AN/A
#4
$3.5M157%$14MN/A
#5
$4.5M170%$53MN/A
#6
$2.7M12-20%N/AN/A
#7
$2.7M1220%N/AN/A
#8
$5.2M196%$15MN/A
#9
$7.9M268%$9.7MN/A
Add Company

What Is Nurami Medical?

Nurami Medical, is an early commercial stage company revolutionizing next-generation surgical products for the repair, regeneration, and safe healing of soft tissues following internal surgeries, based on unique formulations of biomaterials and electrospun nanofiber-based bio-mimetic scaffolds.\n\nOur first product, ArtiFascia®, is an advanced, multi-layer, biomimetic dura repair patch, designed to improve Dura repair in neurosurgeries. ArtiFascia® is FDA-cleared (510K) for use in Dura repair.\n\nTerms of use of our media channels: https://www.nurami-medical.com/terms/

keywords:N/A

$10M

Total Funding

26

Number of Employees

$7.9M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M2856%N/A
#2
$4.1M29-19%N/A
#3
$3.6M31-9%N/A
#4
$3.3M320%N/A
#5
$8.8M3732%N/A